Immune Response Strong After One Dose in COVID-19-Seropositive Vaccinees
Vaccinees with preexisting immunity have antibody titers 10 to 45 times higher than those without preexisting immunity
ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
Event rates for time to first fatal or nonfatal stroke significantly reduced for IPE versus placebo
One Year Into Pandemic, Biden Promises Vaccines for All U.S. Adults by May 1
Remarks came on the one-year anniversary of the WHO declaring COVID-19 to be a pandemic
Teplizumab Could Delay Diagnosis of Type 1 Diabetes
Teplizumab improves beta-cell function in high-risk individuals with relatives who have type 1 diabetes
Guidelines Provided for Unilateral Lymphadenopathy After COVID-19 Vaccination
In most clinical settings, ipsilateral UAL after recent COVID-19 vaccination is benign finding; clinical follow-up recommended
Prevalence of Vascular Risk Factors High for Hispanics/Latinos
Despite high awareness, secondary stroke prevention strategies are low
Genetically Determined Vitamin D Levels Not Linked to T1DM
Genetically determined levels seem not to have a large effect on the risk for type 1 diabetes in Europeans
One-Step Approach IDs More Cases of Gestational Diabetes
No significant difference in perinatal or maternal outcomes found with one-step versus two-step screening approach
Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
Most recipients with anaphylaxis had allergy histories, with 31 percent having prior anaphylaxis
Physical Activity May Improve Cardiorenal Outcomes in CKD
High physical activity level (7.5 to <15 MET hours/week) linked to lower risks for all-cause mortality, ESRD, MACE
